4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0002003059-26-000006
Options or other derivatives
- Chief Commercial Officer acquired 1,134,500 shares (grant or award)
- Chief Commercial Officer returned 1,134,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Robert Paul JR Chief Commercial Officer | 2026-03-19 | Returned to the company · Stock Option (Right to Buy) | −562,500 | 0 | D | ||
| Smith Robert Paul JR Chief Commercial Officer | 2026-03-19 | Returned to the company · Stock Option (Right to Buy) | −572,000 | 0 | D | ||
| Smith Robert Paul JR Chief Commercial Officer | 2026-03-19 | Grant or award · Stock Option (Right to Buy) | +562,500 | 562,500 | D | ||
| Smith Robert Paul JR Chief Commercial Officer | 2026-03-19 | Grant or award · Stock Option (Right to Buy) | +572,000 | 572,000 | D | ||
Loading xslF345X06/wk-form4_1774037994.xml…